| 000 | 01145 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513133948.0 | ||
| 264 | 0 | _c19980204 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0266-9536 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKunkel, M W | |
| 245 | 0 | 0 |
_aCell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs. _h[electronic resource] |
| 260 |
_bAnti-cancer drug design _cDec 1997 |
||
| 300 |
_a659-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
| 650 | 0 | 4 |
_aDisulfides _xpharmacology |
| 650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aThioredoxin-Disulfide Reductase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 700 | 1 | _aKirkpatrick, D L | |
| 700 | 1 | _aJohnson, J I | |
| 700 | 1 | _aPowis, G | |
| 773 | 0 |
_tAnti-cancer drug design _gvol. 12 _gno. 8 _gp. 659-70 |
|
| 999 |
_c9417830 _d9417830 |
||